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INTRODUCTION
The continuous spread of multidrug-resistant path-
ogens has become a serious threat to public health 
and a major concern for infection control practition-
ers worldwide. In addition to increasing the cost of 
drug regimens, this scenario has paved way for the 
reemergence of previously controlled diseases and 
has contributed substantially to the high frequency 
of opportunistic and chronic infection cases in de-
veloping countries. The slow pace of newer antibi-
otic development has provided the need to explore 
nature  in  search  of  phytotherapeutic  agents  with 
novel targets and mode of actions. The practice of 
complementary and alternative medicine is now on 
the increase in developing countries in response to 
World Health Organization directives, culminating 
in several pre-clinical and clinical studies of plants 
used in folk medicine to treat infections (Ako-Nai et 
al., 2003; Fernandez et al., 2003).
Garlic (Allium sativum L.) is one of the oldest 
vegetables, and has been used as a medicinal plant 
(Vijaya and Ananthan, 1997). In particular, because 
garlic has a strong antimicrobial activity and strong 
odor, people have used garlic to preserve meat and 
fish and to mask the smell of their sometimes rotting 
foods. Historically, the antimicrobial activity of garlic 
was recognized by Louis Pasteur (1822-1895), who 
used garlic juice to treat infections, and Albert Sch-
weitzer (1875-1965), who treated amoebic dysentery 
only with garlic (Fenwick and Hanley, 1985; Dilhuy-
dy, 2003). Since the discovery of antibiotics, people no 
longer favor garlic in medical use. However, interest 
in garlic has been revived by the discovery of its an-
tibacterial principle, alk(en)yl thiosulfinates (allicin), 
by Cavallito et al (1945). The growth of more than 
300 kinds of microbes has been found to be inhibited 
by allicin (Reuter et al., 1996), and numerous reports 
have described the antibacterial potential of allicin in 
comparison with that of clinically effective antibiotic 
drugs (Lawson et al., 1991; Kivanc and Kunduhoglu, 
1997; Okochi et al., 2000). Variations in composition 
of garlic and genetic disparity among bacteria of the 
same or different species have been responsible for 
a few inconsistencies in the antibacterial properties 
of garlic extract (Ankri and Mirelman, 1999; Cutler 
and Wilson, 2004), necessitating the need for local 
antibacterial testing of garlic. 
The aim of the present study was to investigate 
the antibacterial activity of an ethanol garlic extract 
(EGE) against local multidrug-resistant bacteria.
MATERIALS AND METHODS
Garlic and ethanol extract preparation
Fresh bulbs of garlic (Allium sativum L.) were pur-
chased from local markets in Belgrade, Serbia. The 1370 IVANA ĆIRKOVIĆ ET AL.
cloves were separated and peeled to obtain the ed-
ible portion. Fifty grams of the edible portion was 
chopped and homogenized in 100 mL of 96% etha-
nol (Zorka Šabac, Serbia). The homogenate was then 
filtered through a 25-mm pore-size filter to give a 
crude ethanol extract of 500 mg of garlic/mL. This 
was collected in a sterile vial and stored at 4ºC until 
used.
Bacterial isolates
A total of 36 Gram-positive and Gram-negative bac-
terial isolates were used in this study; four strains per 
species or serotype of listed bacteria were selected: 
Staphylococcus  aureus,  Staphylococcus  epidermidis, 
Staphylococcus  sciuri,  Enterococcus  faecalis,  Es-
cherichia coli, Klebsiella pneumoniae, Salmonella en-
teritidis, Pseudomonas aeruginosa and Acinetobacter 
baumannii. The isolates were obtained from the Bac-
teriology Department of Clinical Center of Serbia, 
Belgrade, Serbia. The isolates were identified using 
standard procedures (Murray and Baron, 2003). All 
the isolates were clinical strains recovered from pa-
tients with burns, diarrhea, bacteremia, bronchopul-
monary disorder, and urinary tract infections. The 
antibacterial susceptibility profile of the tested organ-
isms was detected by the disk diffusion method ac-
cording to the Clinical Laboratory Standard Institute 
(CLSI) (CLSI, 2010). Stock cultures of bacteria were 
maintained on Tryptone Soya Agar (TSA, bioMer-
ieux, France) at 4°C. Prior to inoculation, all strains 
were transferred from the stock cultures to TSA and 
incubated  overnight  at  35°C.  The  grown  cultures 
were used for the preparation of suspensions in ster-
ile suspension media (SM, bioMerieux) with densi-
ties adjusted to 0.5 McFarland standard. As needed, 
the obtained suspensions were further diluted in SM 
to achieve the appropriate number of cells per ml.
Antibacterial activity
The antibacterial activity of garlic extract was deter-
mined by two techniques: the agar diffusion method 
and agar dilution method. 
For the agar well diffusion method, all bacterial 
strains were used. Suspensions of bacteria contain-
ing 106 CFU/ml were inoculated onto plate surfaces 
with a sterile cotton swab. Test plates (diameter 10 
cm) were prepared with 20 ml of Mueller-Hinton 
agar (bioMerieux) and holes of 6 mm in diameter 
were punched in the agar plates. Each hole was filled 
with 50 μl of EGE or, as the control, with 50 μl of 
95% ethanol. The diameters of the growth inhibition 
zones around the holes were measured after incuba-
tion for 24 h at 35°C. 
The agar dilution method was performed with 
18 bacteria, two strains per species or serotype. Test 
plates were prepared with 19 ml of Mueller-Hinton 
agar, and 1 ml of 2-fold dilutions of EGE. A control 
plate was made with 1 ml of 95% ethanol. After cool-
ing and drying, the plates were spot inoculated with 
10 μl of the 104 CFU/ml suspension. Plates were in-
cubated for 24 h at 35°C, and the minimal inhibitory 
concentrations  (MIC)  were  defined  as  the  lowest 
Table 1. Antibacterial activity of EGE.
Inhibition zone (mm)
Gram-positive bacteria Gram-negative bacteria
Sa Se Ss E Ec K Sl P A
Strain1
Strain2
Strain3
Strain4
29
27
29
29
29
22
22
22
20
24
24
26
12
17
13
17
17
14
23
18
16
18
11
15
16
16
18
16
13
12
11
11
22
21
22
22
Sa – S. aureus, Se – S. epidermidis, Ss – S. sciuri, E – E. faecalis, Ec – E. coli, K – K. pneumoniae, Sl – S. enteritidis, P – P. aeruginosa, A – 
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Fig. 2. Pseudomonas aeruginosa – disk diffusion method with EGE.
Fig. 1. Staphylococcus aureus – disk diffusion method with EGE.1372 IVANA ĆIRKOVIĆ ET AL.
concentration of EGE that inhibited visible growth 
of bacterial spots. 
Synergy assay
The  synergy  assay  was  based  on  a  previously  de-
scribed procedure (Mirzoeva et al., 1997). The syner-
gistic action of EGE with antibiotics was assayed by 
the disc diffusion method on Mueller-Hinton agar. 
One ml of the appropriate EGE dilution and 19 ml 
of the cooled medium were mixed to obtain a con-
centration of EGE which did not inhibit the growth 
of the tested microorganism. Plates containing sub-
inhibitory concentrations of EGE, as well as control 
plates containing 95% ethanol instead of EGE, were 
seeded with the tested bacterial strains as described 
for the agar well diffusion method. The following 
disks  (BioRad,  USA)  were  placed  on  the  seeded 
plates: penicillin (10 U), cephoxitin (30 µg), ampicil-
lin (10 µg), amoxicillin/clavulic acid (20/10 µg), ce-
falotin (30 µg), ceftriaxone (30 µg), piperacillin/tazo-
bactam (100/10 µg), colistin (10 µg), ciprofloxacin (5 
Table 2. Synergism between antibiotics and EGE
Bacteria/antibiotic Synergism Bacteria/antibiotic Synergism
Gram-positive bacteria
S. aureus
penicillin
cephoxitin
gentamicin
erythromycin
clindamycin
vancomycin
ciprofloxacin
S. epidermidis
penicillin
cephoxitin
gentamicin
erythromycin
clindamycin
vancomycin
ciprofloxacin
S. sciuri
penicillin
cephoxitin
gentamicin
erythromycin
clindamycin
vancomycin
ciprofloxacin
E. faecalis
vancomycin
linezolid
amoxicillin/clavulic acid
ampicillin
ciprofloxacin
tetracykline
-
X
X
X
X
X
X
-
X
X
X
X
-
-
-
-
-
X
-
-
-
X
X
X
-
-
X
Gram-negative bacteria
E. coli
ampicillin
cefalotin
piperacillin/tazobactam
cephtriaxon
imipenem
meropenem
amoxicillin/clavulic acid
K. pneumoniae
piperacillin/tazobactam
cefalotin
ciprofloxacin
amoxicillin/clavulic acid
cephtriaxon
meropenem
imipenem
S. enteritidis
gentamicin
ciprofloxacin
ampicillin
amoxicillin/clavulic acid
P. aeruginosa
piperacillin/tazobactam
ciprofloxacin
imipenem
meropenem
colistin
amikacin
A. baumannii
tigecycline
piperacillin/tazobactam
imipenem
meropenem
ciprofloxacin
amikacin
cephtriaxon
-
-
X
X
X
-
X
X
-
-
X
-
X
X
X
-
-
X
-
-
X
-
X
X
X
X
-
-
-
-
-
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µg), vancomycin (30 µg), tetracycline (30 µg), eryth-
romycin (15 µg), clindamycin (2 µg), gentamicin (10 
µg), amikacin (30 µg), tigecycline (10 µg), imipenem 
(10 µg), meropenem (10 µg), and linezolid (30 µg). 
Plates were incubated 24 h at 35°C before the effect 
of EGE was measured by the relation of diameters of 
the growth inhibition zones around the discs in the 
presence of EEP to the diameters of the growth inhi-
bition zones around the discs without the presence of 
EEP (Mirzoeva et al., 1997). 
Statistical analysis
Results  from  the  synergism  assays  were  subjected 
to the Wilcoxon nonparametric test to compare the 
values (mm) of the inhibitory zones obtained by the 
disk diffusion method (Minitab Statistical Software 
version 13.32). Results were considered significant 
when p< 0.05.
RESULTS
Results of the evaluation of antimicrobial activities of 
EGE obtained by the agar diffusion method showed 
significant  antimicrobial  activities  against  Gram-
positive bacteria, but far less against Gram-negative 
bacteria (Table 1). S. aureus was the most susceptible 
bacteria tested in this study (Fig. 1), and P. aerugino-
sa was the most resistant analyzed bacteria (Fig. 2).
More precise information on the antimicrobial 
activities of EGE was obtained by the agar dilution 
method. The MIC for S. aureus, S. epidermidis, S. 
sciuri and A. baumannii was 25 mg/ml, and for E. 
faecalis, E. coli, K. pneumoniae, S. enteritidis, P. aeru-
ginosa, 50 mg/ml.
The results of synergy between the antibacterial 
agents and EGE on the multiresistant strains tested 
in this study are presented in Table 2. 
DISCUSSION
Garlic has been known for ages to exhibit anti-infec-
tive properties against a wide range of microorgan-
isms (Cavallito et al., 1945; Ali Aydin et al., 2007). 
The  present  study  has  further  demonstrated  the 
antibacterial potency of EGE against local multid-
rug-resistant  bacteria  isolated  in  Belgrade,  Serbia. 
The  observed  zones  of  growth  inhibition  on  agar 
of Gram-positive and Gram-negative bacteria show 
that the isolates exhibited susceptibility. This indi-
cates that EGE has a broad spectrum of antibacterial 
activity and a wide therapeutic scope. 
Although  the  antibacterial  properties  of  EGE 
have been the subject of many investigations (Perez-
Giraldo et al., 2003; Cutler et al. 2004; Noori et al., 
2007), it is difficult to compare the results of different 
studies due to the different compositions of EGE and/
or different methods used for the evaluation of EGE 
antibacterial activities (Queiroz et al., 2009). Howev-
er, it is generally recognized that Gram-positive bac-
teria are more susceptible to antibacterial action of 
EGE than Gram-negative bacteria (Cutler and Wil-
son, 2004; Kim et al., 2004; Ali Adydin, 2007), which 
is confirmed in this study on various microorgan-
isms. The result of particular interest in this study is 
that the resistance of the tested bacteria to antibiotics 
had no influence on susceptibility to EGE.
The isolates tested in this study are responsible for 
many diseases in Serbia, including nosocomial infec-
tions, bacteremia and diarrheal diseases (Wu, 2008). 
The sensitivity of these isolates to EGE implies that 
the intrinsic biosubstances in this extract are naive 
to the various drug resistance factors of the isolates, 
which include beta-lactamase expression, increased 
pyrrolidonyl  arylamidase  activity,  aminoglycoside-
modifying enzymes, and altered ribosomal binding. 
Several  studies,  including  those  of  Kim  et  al. 
(2004) and Lacombe et al. (2010), had previously 
demonstrated  the  antibacterial  potency  of  EGE 
against enteropathogens such as Vibrio parahaemo-
lyticus, E. coli, Klebsiella spp., Proteus spp., and S. 
aureus. In spite of geographical variation, the MICs 
of EGE for our isolates are consistent with those of 
Yin and Cheng (2003) and Yang et al. (2011), but are 
relatively lower than values obtained by Kim et al. 
(2004). This antibacterial potency disparity of garlic 
has been attributed to the different concentrations of 1374 IVANA ĆIRKOVIĆ ET AL.
individually and synergistically active biosubstances 
in  garlic  preparations,  coupled  with  their  interac-
tions with sulfhydryl agents in culture media. This 
phenomenon has been used to explain the stronger 
antimicrobial effect of allicin than garlic oil disulfides 
(Fujisawa et al., 2009). 
The results of the synergistic action of EGE with 
antibiotics demonstrated the potential of garlic to en-
hance antibiotic action. Thus, they support previous 
findings on the synergistic action between antibiot-
ics and garlic (Betoni et al., 2006; Cai et al., 2007). 
However, EGE showed different potential to different 
antibiotics and bacteria. The inhibition zones around 
the disks of antibiotics, on which EGE had influence, 
were larger in Gram-positive bacteria then in Gram-
negative bacteria. A combination of garlic and anti-
bacterial agents could allow a reduction in the dose 
of selected antibiotics and potentiation of the anti-
bacterial therapy (Palaksha et al., 2010). 
In conclusion, this study has shown that garlic 
has significant antibacterial potential against bacte-
ria, but the effect is species-dependent. The resist-
ance of the tested bacteria to antibiotics has no influ-
ence on susceptibility to EGE. The illustrated ability 
of garlic to enhance antibiotics is of potential medi-
cal interest. Therefore, complementary and alterna-
tive medicine practices with plant extracts, including 
garlic, as a means of decreasing the burden of drug 
resistance and reducing the cost of the management 
of disease, could be of clinical and public health im-
portance in this country.
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